StockGlow

Insmed Incorporated (IM8N.F)

Insmed Incorporated develops and commercializes therapies for patients with serious and rare diseases in the United States, Europe, Japan, and internationally.

88.57-0.02%Healthcare
Compare IM8N.F with
StockGlow Score
7
Bearish
BearishBullish
1 year ago-4.8%

The outlook

Insmed Incorporated currently reads as bearish based on below its 50- & 200-day averages, 9% of the way from its 52-week low to high. This is a snapshot of current market data, not a forecast.

What’s behind the score

Price trendBelow its 50- & 200-day averages
52-week range9% of the way from its 52-week low to high
Market cap
$19.20B
52-wk high
185.00
52-wk low
78.77
50-day avg
91.52
200-day avg
126.44
Trailing P/E
—

Similar stocks

IM8N.SGInsmed Incorporated$88.81+1.52%DR6.FACADIA Pharmaceuticals Inc.$23.02+0.61%2L9.FVisionWave Holdings, Inc.$1.63-3.66%KK3A.FCytokinetics, Incorporated$69.26-1.34%UP0.FUltragenyx Pharmaceutical Inc.$22.52+4.89%

The StockGlow Score is a snapshot of current, observable market data (analyst ratings, price trend, 52-week range) — not a prediction, forecast, or recommendation. Informational only, not investment advice. Data from public sources and may be delayed. How this works·Privacy